Related Experiment Video

Updated: Oct 17, 2025

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

4.8K

Personalized medicine for multiple sclerosis: How to integrate neurofilament light chain levels in the decision?

Pablo Villoslada1

  • 1Stanford University, Stanford, CA, USA/Institut d'Investigacions Biomediques August Pi Sunyer, Barcelona, Spain.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 6, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.9K

Related Experiment Videos

Last Updated: Oct 17, 2025

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

4.8K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.9K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K

Articles linked to this work by shared authors, journal, and citation graph.

Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis Optica.

Annals of clinical and translational neurology·2025

Multiscale networks in Alzheimer's disease identify brain hypometabolism as central across biological scales.

PLoS computational biology·2025

The Present and Future of Monoclonal Antibody Therapies for Multiple Sclerosis.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2025

Retinal Damage and Visual Network Reconfiguration Defines Visual Function Recovery in Optic Neuritis.

Neurology(R) neuroimmunology & neuroinflammation·2024

Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum Disorders.

Neurology(R) neuroimmunology & neuroinflammation·2024

Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores.

Neurology(R) neuroimmunology & neuroinflammation·2024

Peripartum mental illness in serial pregnancies in mothers with multiple sclerosis and other chronic diseases.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Use of patient reported outcomes in multiple sclerosis clinical management: Scoping literature review.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Serum NfL predicts visual recovery and neuronal loss after optic neuritis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Retinal vessel diameters in multiple sclerosis: associations with disability, cardiovascular risk factors and retinal atrophy.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

A group resilience training program for people with multiple sclerosis: A cluster-randomized controlled trial (multi-READY for MS).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Cesarean sections prior to 39 weeks among pregnant patients with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

The journey to establishing systems of care for all children, starting at birth: the Society for Pediatric Research's 2026 Mary Ellen Avery award.

Pediatric research·2026

Targeting the Metabolic-Immune Regulator SLC35F6 Enhances Temozolomide and Anti-PD-L1 Therapy in Glioma.

Cancer letters·2026

Opportunistic Prenatal Genetic Testing During Fetoscopic Laser Surgery for Twin-Twin Transfusion Syndrome.

Prenatal diagnosis·2026

Can tissue engineering applications replace cardiovascular medical devices? Searching for the key to clinical translation.

Biomaterials advances·2026

Horizon Scanning of Multiple Sclerosis Expenditure in Italy (2025-2029): Updated Insights from the Oracle Model.

Neurology and therapy·2026

A Review of Minimally Invasive Therapies for Men with Overactive Bladder.

Current urology reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us